Coretag Diagnostics

Targeting for Quality of Life.

Necrosis appears in pathological conditions like stroke, myocardial infarction, gangrene and aggressively growing tumors and metastasis.

Based on its proprietary necrosis targeting platform technology, Coretag Diagnostics AG develops targeted diagnostics with 89Zr (zirconium) and 111In (indium) for detecting and quantifying necrotic tissue in the human body.